Compare PTCT & GBCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTCT | GBCI |
|---|---|---|
| Founded | 1998 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.3B |
| IPO Year | 2006 | 1996 |
| Metric | PTCT | GBCI |
|---|---|---|
| Price | $62.76 | $43.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 5 |
| Target Price | ★ $79.41 | $53.60 |
| AVG Volume (30 Days) | ★ 1.0M | 966.7K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.98% |
| EPS Growth | ★ 264.48 | 18.45 |
| EPS | ★ 7.78 | 1.99 |
| Revenue | ★ $264,734,000.00 | N/A |
| Revenue This Year | N/A | $30.38 |
| Revenue Next Year | $21.65 | $8.37 |
| P/E Ratio | ★ $8.14 | $22.36 |
| Revenue Growth | ★ 36.19 | N/A |
| 52 Week Low | $35.95 | $36.76 |
| 52 Week High | $87.50 | $53.99 |
| Indicator | PTCT | GBCI |
|---|---|---|
| Relative Strength Index (RSI) | 21.26 | 30.64 |
| Support Level | $57.74 | $43.01 |
| Resistance Level | $63.19 | $43.90 |
| Average True Range (ATR) | 2.77 | 1.59 |
| MACD | -0.57 | -0.77 |
| Stochastic Oscillator | 8.82 | 14.98 |
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.
Glacier Bancorp Inc is a regional bank holding company providing commercial banking services to scores of communities through its wholly-owned bank subsidiary, Glacier Bank. The bank operates a multitude of banking offices in Montana, Idaho, Colorado, Utah, Washington, and Wyoming. The bank's various products and services include deposit, loans, and mortgage origination services, among others. The bank predominantly serves individuals, small- to medium-sized businesses, community organizations, and public entities. Glacier emphasizes both internal growth and growth through selective acquisitions. A majority of the bank's loan portfolio is in commercial real estate, while a majority of its net revenue is net interest income.